Psychiatry - Schizophrenia/Psychosis News & Articles

41 Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countries Full Text Cost Effectiveness and Resource Allocation, June 11, 2013    Clinical Article

42 The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients International Journal of Neuropsychopharmacology, June 11, 2013    Clinical Article

43 Demographic, socio-environmental, and substance-related predictors of duration of untreated psychosis (DUP) Schizophrenia Research, June 11, 2013    Clinical Article

44 Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia Schizophrenia Research, June 11, 2013    Clinical Article

45 Neural markers of negative symptom outcomes in distributed working memory brain activity of antipsychotic-naive schizophrenia patients International Journal of Neuropsychopharmacology, June 11, 2013    Clinical Article

46 Chinese translation and validation of the questionnaire on the process of recovery in schizophrenia and other psychotic disorders Research in Nursing & Health, June 11, 2013    Clinical Article

47 Biological basis for cerebral dysfunction in schizophrenia in contrast with alzheimers disease Frontiers in Psychiatry, June 11, 2013    Review Article

48 The subjective experience and phenomenology of depression following first episode psychosis: a qualitative study using photo-elicitation Journal of Affective Disorders, June 10, 2013    Clinical Article

49 The Early Recognition Inventory ERIraos detects at risk mental states of psychosis with high sensitivity Comprehensive Psychiatry, June 10, 2013    Clinical Article

50 Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia Psychiatry and Clinical Neurosciences, June 10, 2013    Clinical Article

51 Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses Brain, Behavior, and Immunity, June 10, 2013    Clinical Article

52 The evidence for illness progression after relapse in schizophrenia Schizophrenia Research, June 10, 2013    Clinical Article

53 Is aberrant functional connectivity a psychosis endophenotype? a resting state functional magnetic resonance imaging study Biological Psychiatry, June 10, 2013    Clinical Article

54 Mephentermine dependence with psychosis General Hospital Psychiatry, June 10, 2013

55 Preventing the development of metabolic syndrome in people with psychotic disorders-difficult, but possible: experiences of staff working in psychosis outpatient care in Sweden Issues in Mental Health Nursing, June 10, 2013    Clinical Article

56 Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis JAMA Psychiatry, June 7, 2013    Clinical Article

57 White matter microstructure in individuals at clinical high risk of psychosis: a whole-brain diffusion tensor imaging study Schizophrenia Bulletin, June 7, 2013    Clinical Article

58 The cognitive biases questionnaire for psychosis (CBQ-P) and the davos assessment of cognitive biases (DACOBS): validation in a flemish sample of psychotic patients and healthy controls Schizophrenia Research, June 7, 2013    Clinical Article

59 Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study Progress in Neuro-Psychopharmacology and Biological Psychiatry, June 7, 2013    Clinical Article

60 Adapting and evaluating a social cognitive remediation program for schizophrenia in Arabic Schizophrenia Research, June 7, 2013    Clinical Article

1 NMDA receptor antagonists interventions in schizophrenia: meta-analysis of randomized, placebo-controlled trials Journal of Psychiatric Research, May 28, 2013    Evidence Based Medicine    Review Article

2 Open-label pilot study on vitamin D3 supplementation for antipsychotic-associated metabolic anomalies International Clinical Psychopharmacology, May 22, 2013

3 Informing DSM 5: Biological boundaries between Bipolar I, Schizoaffective, and Schizophrenia BMC Medicine, May 17, 2013    Free full text

4 Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trials European Neuropsychopharmacology, April 29, 2013    Evidence Based Medicine    Review Article

5 Plasma levels of second-generation antipsychotics and clinical response in acute psychosis: A review of the literature Schizophrenia Research, May 15, 2013    Review Article

6 ABC Schizophrenia study: an overview of results since 1996 Social Psychiatry and Psychiatric Epidemiology, May 7, 2013

7 Benzodiazepines for psychosis-induced aggression or agitation Cochrane Reviews, May 9, 2013

8 Life Events and Psychosis: A Review and Meta-analysis Schizophrenia Bulletin, May 16, 2013    Evidence Based Medicine    Review Article

9 Drug information update: paliperidone palmitate for schizophrenia The Psychiatrist, May 3, 2013    Review Article

10 Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial Schizophrenia Research, May 6, 2013

11 Practical management of schizophrenia: The role of long-acting Antipsychotics International Clinical Psychopharmacology, May 20, 2013

12 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine

13 Is T-helper type 2 shift schizophrenia-specific? Primary results from a comparison of related psychiatric disorders and healthy controls Psychiatry and Clinical Neurosciences, May 21, 2013

14 Associations of White Matter Integrity and Cortical Thickness in Patients With Schizophrenia and Healthy Controls Schizophrenia Bulletin, May 14, 2013

15 Rates and predictors of remission in first-episode schizophrenia within 1year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia Schizophrenia Research, May 7, 2013

16 Rapid Improvement of Acute Schizophrenia Symptoms After Intravenous Sodium Nitroprusside JAMA Psychiatry, May 9, 2013

17 Brain structural, neurochemical and neuroinflammatory markers of psychosis onset and relapse: Is there evidence for a psychosis relapse signature? International Clinical Psychopharmacology, May 16, 2013    Review Article

18 Semantic processes leading to true and false memory formation in schizophrenia Schizophrenia Research, May 1, 2013

19 A family affair: brain abnormalities in siblings of patients with schizophrenia Brain, May 24, 2013    Review Article

20 Increased plasma agmatine levels in patients with schizophrenia Journal of Psychiatric Research, May 13, 2013